Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Gastroenterology

What Is the Spigelman Staging System for FAP Polyps?

At a Glance

In FAP, the Spigelman system scores duodenal polyps by their number, size, growth pattern, and cell changes, producing a total from 0 to 12. The stage estimates the risk of precancerous changes and guides surveillance, but it is not a cancer stage and does not score the ampulla separately.

When you have Familial Adenomatous Polyposis (FAP), your doctor will perform regular upper endoscopies to check your upper digestive tract for polyps. While they will look at your stomach, the severity of polyps in your duodenum (the first part of your small intestine) is measured using a specific scoring method called the Spigelman classification system [1][2].

It is important to know that the Spigelman stage is a tool to measure the risk of precancerous changes; it is not a cancer stage, and a high Spigelman stage does not mean you have cancer [3]. Stomach polyps are assessed separately and do not factor into this score [1]. Instead, your Spigelman stage helps your care team evaluate your risk for duodenal cancer over time, which helps guide how soon you need your next endoscopy or whether specialized treatments are needed [4].

How the Spigelman Score is Calculated

Your Spigelman score combines findings from two different reports: your endoscopy report (what the doctor saw during the procedure) and your pathology report (what the microscope showed from biopsies) [1]. Your doctor assigns 1 to 3 points across four categories [1]:

From your Endoscopy Report:

  • Number of polyps: 1 to 4 polyps (1 point); 5 to 20 polyps (2 points); more than 20 polyps (3 points).
  • Polyp size: 1 to 4 mm (1 point); 5 to 10 mm (2 points); larger than 10 mm (3 points) [5].

From your Pathology Report:

  • Histology (Growth pattern): Tubular (1 point); Tubulovillous (2 points); Villous (3 points) [5].
  • Dysplasia (How abnormal the cells look): Low-grade (1 point); High-grade (3 points). High-grade dysplasia means the cells look significantly abnormal (precancerous), though this is still not invasive cancer [5].

(Note: If zero polyps are found, your score is 0).

These points are added together for a total score of 0 to 12. This score directly corresponds to your Spigelman stage [1]:

Total Points Spigelman Stage
0 Stage 0
1 to 4 Stage I
5 to 6 Stage II
7 to 8 Stage III
9 to 12 Stage IV

What the Stages Mean for Your Care

Your Spigelman stage helps guide your surveillance plan [1]. Guidelines and individual patient risks vary, so the exact timing of your next endoscopy depends on your overall health, symptoms, and previous treatments. However, typical intervals are [4]:

  • Stage 0 or I: Surveillance endoscopy typically every 4 to 5 years [4].
  • Stage II: Surveillance endoscopy typically every 3 years [4].
  • Stage III: Surveillance typically every 1 to 2 years (or 6 to 12 months, depending on specific findings like polyp growth or high-grade dysplasia) [4].
  • Stage IV: This stage indicates a high burden of precancerous polyps. Surveillance is typically required every 6 months [4]. At this stage, you should be evaluated by a multidisciplinary team at an expert FAP center [6]. Advanced endoscopists may use specialized techniques to remove or destroy polyps, which can sometimes reduce your score [7]. If the polyps are growing rapidly, contain high-grade dysplasia, or cannot be safely managed with an endoscope, your care team will discuss risk-reducing surgery to remove part of the duodenum [8][9].

An Important Missing Piece: The Ampulla

The Spigelman stage has one major limitation: it does not specifically score the ampulla of Vater (the small opening where bile and pancreatic fluids enter the duodenum) [4].

Research shows that a substantial and highly variable proportion of FAP-related upper intestinal cancers occur at or near the ampulla, meaning a Spigelman Stage IV alone does not capture all cancer risk [3][4]. Because standard endoscopes look straight ahead, your doctor may need to use a special side-viewing scope to properly assess the ampulla [4]. If you have ampullary polyps, you should ideally be evaluated at an FAP center, as these lesions require separate, careful management [6].

When to Contact Your Doctor

Many people with duodenal polyps have no physical symptoms, which is why sticking to your scheduled surveillance is so important even when you feel well [4]. However, do not wait for your next scheduled endoscopy if you develop concerning signs. Contact your doctor immediately or seek urgent care if you experience [4]:

  • Black, tarry, or bloody stools
  • Persistent vomiting or the inability to keep fluids down
  • Yellowing of your skin or eyes (jaundice)
  • Severe or rapidly worsening abdominal pain
  • Unexplained weight loss, fainting, or extreme weakness

Common questions in this guide

What does the Spigelman stage measure in FAP?
The Spigelman stage estimates the risk of precancerous changes from duodenal polyps in people with FAP. It is not a cancer stage, and stomach polyps are not included in the score.
How is a Spigelman score calculated?
Doctors assign points for the number and size of duodenal polyps, their growth pattern under the microscope, and the degree of dysplasia, or abnormal cell change. The points are added to produce a total from 0 to 12; a score of 0 means no polyps were found.
What do Spigelman stages 0 through IV mean?
Stage 0 corresponds to 0 points, stage I to 1–4 points, stage II to 5–6 points, stage III to 7–8 points, and stage IV to 9–12 points. Higher stages generally reflect a greater burden of precancerous duodenal polyps and require closer medical follow-up.
How often is surveillance endoscopy recommended for each Spigelman stage?
Typical intervals are every 4–5 years for stages 0 or I, every 3 years for stage II, and every 1–2 years for stage III, sometimes every 6–12 months. Stage IV usually requires endoscopy about every 6 months and evaluation at an expert FAP center, although the exact plan depends on individual findings.
Does the Spigelman score include the ampulla of Vater?
No. The ampulla of Vater is assessed separately because it is not included in the Spigelman score. A side-viewing endoscope may be needed to examine it properly, especially when an ampullary polyp is suspected.
Does a high Spigelman stage mean that I have cancer?
No. A high stage indicates a higher burden of precancerous duodenal polyps, not invasive cancer. High-grade dysplasia means cells look significantly abnormal, but it is still not the same as invasive cancer.
Which symptoms should prompt urgent medical attention in someone with FAP?
Seek prompt medical care for black or bloody stools, persistent vomiting or inability to keep fluids down, jaundice, severe or rapidly worsening abdominal pain, unexplained weight loss, fainting, or extreme weakness. These symptoms should not wait for the next scheduled endoscopy.

Get notified when new evidence is published on Familial Adenomatous Polyposis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.

    Hurley JJ, Thomas LE, Walton SJ, et al.

    Gastrointestinal endoscopy 2018; (88(4)):665-673 doi:10.1016/j.gie.2018.04.2347.

    PMID: 29702101
  2. 2

    Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review.

    Silverman AL, Bouchiba H, Aelvoet A, et al.

    Endoscopy international open 2024; (12(6)):E799-E809 doi:10.1055/a-2330-8037.

    PMID: 38904059
  3. 3

    The Spigelman Staging System and the Risk of Duodenal and Papillary Cancer in Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis.

    Mannucci A, Puzzono M, Goel A, et al.

    The American journal of gastroenterology 2024; (119(4)):617-624 doi:10.14309/ajg.0000000000002688.

    PMID: 38294150
  4. 4

    Endoscopic management of duodenal adenomatosis in familial adenomatous polyposis-A case-based review.

    Soons E, Bisseling TM, van Kouwen MCA, et al.

    United European gastroenterology journal 2021; (9(4)):461-468 doi:10.1002/ueg2.12071.

    PMID: 34529357
  5. 5

    Spigelman stage IV duodenal polyposis does not precede most duodenal cancer cases in patients with familial adenomatous polyposis.

    Thiruvengadam SS, Lopez R, O'Malley M, et al.

    Gastrointestinal endoscopy 2019; (89(2)):345-354.e2 doi:10.1016/j.gie.2018.07.033.

    PMID: 30081000
  6. 6

    Endoscopic management of duodenal lesions in familial adenomatous polyposis: A tertiary referral center experience.

    Scardino A, Benedicenti F, Ferrari D, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; doi:10.1016/j.dld.2026.08.014.

    PMID: 42711179
  7. 7

    Impact of Endoscopic Treatment in Severe Duodenal Polyposis: A National Study in Familial Adenomatous Polyposis Patients.

    Le Bras P, Cauchin E, De Lange G, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(9)):1839-1846.e1 doi:10.1016/j.cgh.2024.03.007.

    PMID: 38555039
  8. 8

    Pancreas- and Pylorus-Preserving Duodenectomy for Advanced Familial Duodenal Polyposis.

    Leite JS, Tralhão JG, Manso A, et al.

    GE Portuguese journal of gastroenterology 2020; (27(3)):185-191 doi:10.1159/000503010.

    PMID: 32509924
  9. 9

    Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?

    Sourrouille I, Lefèvre JH, Shields C, et al.

    Diseases of the colon and rectum 2017; (60(11)):1137-1146 doi:10.1097/DCR.0000000000000903.

    PMID: 28991077

This page explains the Spigelman score in FAP for informational purposes only and does not constitute medical advice. Your gastroenterologist and care team should interpret your reports and determine your surveillance or treatment plan.